The intraocular pressure reducing effect of Latanoprost has been shown to be additive to that of beta-adrenergic antagonists (timolol), adrenergic agonists (dipivalyl epinephrine), carbonic anhydrase inhibitors (acetazolamide), and at least partly to cholinergic agonist (pilocarpine) in short term clinical trials.
Sign Out
